Tomorrow’s Analytical Cannabis Track Keynote Talk—Day 2
September 14—Baltimore, Maryland—Lori Dodson, Deputy Director of the Maryland Medical Cannabis Commission, will give a special welcome talk tomorrow in the analytical meeting room at 9:00 a.m. The talk is titled “Special Welcome from the Maryland Medical Cannabis Commission.”
Lori Dodson, Deputy Director of the Maryland Medical Cannabis Commission, will give a special welcome talk tomorrow in the analytical meeting room at 9:00 a.m. The talk is titled “Special Welcome from the Maryland Medical Cannabis Commission.”
Join Lori Dodson from the Maryland Medical Cannabis Commission for a special welcome to Maryland to our 2021 Cannabis Science Conference East attendees. Over her career at the Commission, Lori oversaw laboratory compliance and worked to advance cannabis science and education.
Lori Dodson currently serves as the Deputy Director for the Maryland Medical Cannabis Commission. During her time with the Commission, Lori has been actively involved in developing policies and regulations for the medical cannabis industry in Maryland, as well as developing criteria and tolerances for the laboratories registered to certify medical cannabis. Prior to coming on board at the commission, Lori was a Program Coordinator for the Maryland Department of Health and Mental Hygiene-Office of Health Care Quality.
For more information on the analytical track, please visit the 2021 Cannabis Science Conference East Final Program & Exhibitor Guide.
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
